AV
Avicanna Inc.
AVCNF · OTC
$0.08 -1.42% (-$0.00)
1M -20.75%
Market Cap $13.4M
P/E Ratio -
Div. Yield -
ROE 108.40%
Bulios Fair Price
$0.05
33.3% downside
Current Price
$0.075
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVCNF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
84 /100
Cheap P/S 0.53x
P/B 2.92x
P/E N/A
Growth
100 /100
Growing Rev. growth 84.59%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 51.87%
Net margin 15.45%
FCF margin 13.28%
Quality
13 /100
Poor ROIC 25.46%
ROE 108.40%
Asset turnover 1.05x
Debt
54 /100
Moderate Debt/Equity 0.04x
Current ratio 0.97x
Int. coverage -64.06x
Stability
37 /100
Moderate Beta 0.33x
Rev. volatility 168.85%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVCNF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Aras Azadian Mba
Employees
112
Headquarters
Toronto
Upcoming events
13 NOV
Earnings
Upcoming earnings report